According to the new market research report Defibrillators Market is projected to reach USD 10,883.3 million by 2022 from USD 9,323.5 million in 2017 at a CAGR of 3.1%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549
Factors such as technological advancements in defibrillators, rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training & awareness programs on defibrillators are expected to propel the growth of this market. However, issues related to the use of implantable and automated external defibrillators are expected to restrain the growth of the defibrillators market in the forecast period.
The ICDs segment is expected to account for the largest share of the global market in 2017. Factors such as the development of technologically advanced devices with extended longevity, rapid growth in the number of implant procedures, and increasing adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) and S-ICD systems across the globe are contributing to the large share of this segment.
ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs).
Know How this Report Will Help You!
> What are the Known and Unknown Adjacencies Impacting the Defibrillators Market?
> What will your New Revenue Sources be?
> Who will be your Top Customer; what will make them switch?
> Defend your Market Share or Win Competitors
> Get a Scorecard for Target Partners
On the basis of products, the external defibrillator market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs).
Among the end users, the public access defibrillators markets segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment is attributed to the development of advanced AEDs, rising cases of sudden cardiac arrest at out-of-hospital settings, and increasing number of public access defibrillation programs across the globe.
North America dominated the global defibrillators market in 2017
The large share of the North American external defibrillator market can mainly be attributed to the continuous technological advancements and product innovations, increasing number of public defibrillation programs, and rising focus of key players to expand their business in the North American region.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=549
As of 2016, prominent players in the defibrillators market include Medtronic (Ireland), St. Jude Medical (US), Boston Scientific (US), Philips (the Netherlands), ZOLL Medical (US), BIOTRONIK (Germany), Physio-Control (US), Cardiac Science (US), LivaNova (UK), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey) are some major players in the global market.
Defibrillators Market Size, Share, Trends - Analysis Report 2022
The global Wearable Cardioverter Defibrillators Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the wearable cardioverter defibrillators market include ZOLL Medical Corporation, Medtronic, St. Jude Medical LLC, Boston Scientific Corporation, LivaNova, Koninklijke Philips N.V., Cardiac Science, Physio-Control Inc., Nihon Kohden Corporation, Defibtech LLC.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Wearable Cardioverter Defibrillators Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/wearable-cardioverter-defibrillators-market/download-sampleMarket DynamicsThe increasing rate of cardiovascular diseases worldwide is augmenting the market growth.
Moreover, the rising awareness due to the campaigns organized by certain health organizations, hospitals and NGOs is likely to boost the market growth.
However, the lack of trained staff and technicians to monitor the device is likely to hinder the market growth.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
The global Wearable Cardioverter Defibrillators Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the wearable cardioverter defibrillators market include ZOLL Medical Corporation, Medtronic, St. Jude Medical LLC, Boston Scientific Corporation, LivaNova, Koninklijke Philips N.V., Cardiac Science, Physio-Control Inc., Nihon Kohden Corporation, Defibtech LLC.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Wearable Cardioverter Defibrillators Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/wearable-cardioverter-defibrillators-market/download-sampleMarket DynamicsThe increasing rate of cardiovascular diseases worldwide is augmenting the market growth.
Moreover, the rising awareness due to the campaigns organized by certain health organizations, hospitals and NGOs is likely to boost the market growth.
However, the lack of trained staff and technicians to monitor the device is likely to hinder the market growth.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.